학술논문
Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial
Document Type
Article
Author
Haddad, Robert; Guigay, Joel; Keilholz, Ulrich; Clement, Paul M.; Fayette, Jérôme; de Souza Viana, Luciano; Rolland, Frédéric; Cupissol, Didier; Geoffrois, Lionnel; Kornek, Gabriela; Licitra, Lisa; Melichar, Bohuslav; Ribaldo Nicolau, Ulisses; Rauch, Daniel; Zanetta-Devauges, Sylvie; Cohen, Ezra E.W.; Machiels, Jean-Pascal; Tahara, Makoto; Vermorken, Jan; Geng, Yuan; Zografos, Eleftherios; Gauler, Thomas
Source
In Oral Oncology October 2019 97:82-91
Subject
Language
ISSN
1368-8375